1) Walker-256 hepatoma model
Walker-256肝移植模型
1.
The effect of Bcl-2、P53 in rat walker-256 hepatoma model after combination embolization with ribonuclease inhibitor plus TACE;
RI与TACE联合栓塞Walker-256肝移植模型肿瘤组织中Bcl-2、P53的表达
2) Walker-256
Walker-256肝癌模型
3) Walker-256 transplanted hepatocarcinoma
Walker-256移植性肝肿瘤
4) Walker-256 liver cancer
Walker-256肝癌
1.
Effects of Erbie San on Walker-256 liver cancer and adjustment to unbalance of VEGF/endostatin in rats
二鳖散对大鼠Walker-256肝癌肿瘤生长及血清VEGF,endostatin表达的影响
5) Walker-256 hepatocarcine line
Walker-256肝癌株
6) Walker-256 hepatocarcinoma cell lines
Walker-256肝癌细胞
1.
METHODS:Walker-256 hepatocarcinoma cell lines were treated with ATRA at various concen- trations(100,10,5 and 1μmol/L,respectively).
目的:观察ATRA对Walker-256肝癌细胞的分化诱导及促进凋亡作用,探讨其作用机制。
补充资料：背驮式肝移植
背驮式肝移植
piggyback liver transplantation,PBLT
即为保留受者下腔静脉的原位肝移植。在原位肝移植病肝切除后的无肝期内，常规的方法经阻断肝上、肝下、下腔静脉，引起下肢、肾脏的静脉回流受阻导致全身血流动力学的改变。而保留受者的下腔静脉则可使血流动力学紊乱大为减轻。术中不必采用体外静脉转流术。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条